Search results for "Highlights"


 
Results 61 - 70 of about 443 for "Highlights".
Sort by: Relevance | Newest | Oldest

Time-restricted eating may help improve metabolic status

People who time-restricted their eating had decreased body weight and fat mass and improved lipid values but did not show improvements in waist circumference, HbA1c level, or blood pressure, a systematic review and meta-analysis found.
https://diabetes.acponline.org/archives/2022/10/14/2.htm
14 Oct 2022

Gestational diabetes associated with risks later in life, but lifestyle makes a difference, studies find

A review found increased risks of cardiovascular and cerebrovascular disease in women who had gestational diabetes, while another study showed that five markers of a healthy lifestyle were associated with a significant reduction in risk of developing type 2 diabetes after gestational diabetes.
https://diabetes.acponline.org/archives/2022/10/14/8.htm
14 Oct 2022

Avoiding hypoglycemia most compelling reason for deintensifying diabetes meds

Researchers presented older adults with type 2 diabetes with three scenarios in which deintensification may be indicated—poor health, limited life expectancy, and high hypoglycemia risk—and found that 8%, 4%, and 75%, respectively, viewed deintensification positively.
https://diabetes.acponline.org/archives/2022/10/14/3.htm
14 Oct 2022

ADA, KDIGO offer consensus statements on managing diabetes and chronic kidney disease

The American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) provided specific advice on use of metformin, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and nonsteroidal mineralocorticoid receptor antagonists in patients with diabetes and chronic kidney disease.
https://diabetes.acponline.org/archives/2022/10/14/1.htm
14 Oct 2022

Initiation of glucose-lowering therapies may be associated with reduced physical activity

An analysis of 148 participants from three randomized trials found that starting liraglutide, empagliflozin, or sitagliptin was associated with reduction in physical activity of about 1,000 steps per day or 10 minutes of moderate to vigorous physical activity per day.
https://diabetes.acponline.org/archives/2022/09/16/2.htm
16 Sep 2022

Patients diagnosed by OGTT without elevated HbA1c had similar CV, renal disease risks as those without diabetes

A prospective U.K. study found that patients with diabetes based on an oral glucose tolerance test (OGTT) often did not have a diabetic HbA1c level, and risks of cardiovascular (CV) and kidney disease in these patients were similar to those in the nondiabetic general population.
https://diabetes.acponline.org/archives/2022/09/16/3.htm
16 Sep 2022

Program directs stable diabetes patients from endocrinology back to primary care

One academic health system developed a program to “graduate” patients out of endocrinology visits for their diabetes. Criteria included HbA1c level less than 8.0%, blood pressure less than 140/90 mm Hg, no tobacco use, and use of statins and aspirin if needed.
https://diabetes.acponline.org/archives/2022/09/16/1.htm
16 Sep 2022

Comprehensive telehealth approach improved HbA1c in type 2 diabetes

Compared with a simpler approach of telemonitoring and care coordination, an intervention that added self-management and diet/activity support, medication management, and depression care improved outcomes in veterans with poorly controlled type 2 diabetes, a trial found.
https://diabetes.acponline.org/archives/2022/08/12/2.htm
12 Aug 2022

Review finds blood pressure-lowering effects weaker in patients with type 2 diabetes

Absolute risk reductions did not differ substantially between people with and without type 2 diabetes because of the higher absolute cardiovascular risk among those with the condition, according to a new meta-analysis.
https://diabetes.acponline.org/archives/2022/08/12/1.htm
12 Aug 2022

Glucose-lowering treatment after type 2 diabetes diagnosis differed by race/ethnicity

Among 77,199 patients in a U.S. health system with a new diagnosis of diabetes from 2005 to 2016, 47% started a diabetes medication within 12 months. Prevalence differed by race and ethnicity, although the difference was mitigated by variation in HbA1c levels.
https://diabetes.acponline.org/archives/2022/08/12/3.htm
12 Aug 2022

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next